A Case of Cunninghamella bertholettiae Rhino-cerebral Infection in a Leukaemic Patient and Review of Recent Published Studies
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
Cunninghamella bertholletiae infection occurs most frequently in neutropenic patients affected by haematological malignancies, is associated with an unfavourable outcome. We report a case of rhino-mastoidal fungal infection in a leukaemic patient. Bioptical tissue cultures yield the isolation of a mould with typical properties of Cunninghamella species. Liposomal amphotericin B (L-Amb) therapy combined with surgical intervention brought the lesion to recovery. Nevertheless, the patient died 14 days after bone marrow transplantation (BMT) from bacterial sepsis. Mastoiditis was documented at CT-scan. The conditioning regimen probably caused the reactivation of the Cunninghamella infection that led to the patient’s fatal outcome; fungal hyphae were detected after autopsy of brain and lung tissue.
- Maloisel F, Dufour P, Waller J, et al. Cunninghamella bertholletiae: an uncommon agent of opportunistic fungal infection: case report and review of the literature. Bone Marrow Transplant. 2000;25:1213–6. CrossRef
- Passos XS, Sales WS, Maciel PJ, Costa CR, Ferreira DM, do Silva MR. Nosocomial invasive infection caused by Cunninghamella bertolletiae: case report. Mycopathologia. 2006;161:33–5. CrossRef
- Sands JM, Macher AM, Ley TJ, Nienhuis AW. Disseminated infections caused by Cunninghamella bertolletiae in a patient with β-thalassemia. Ann Intern Med. 1995;102:59–63.
- Zeilender S, Drenning S, Glauser FL, Bechard D. Fatal Cunninghamella bertolletiae infection in an immunocompetent patient. Chest. 1990;97:1482–3. CrossRef
- Hutter RVP. Phycomicetes infection (mucormicosis) in cancer patients: complication of therapy. Cancer. 1959;12:330–50. CrossRef
- Ribes JA, Vanover-Sams CL, Baker DJ. Zigomycetes in human disease. Clin Microbiol Rev. 2000;13:236–301. CrossRef
- Boyce JM, Lawson LA, Lockwood WR, Hughes JR. Cunninghamella bertholletiae wound infection of probable nosocomial origin. South Med J. 1981;74:1132–5.
- Kontoyiannis DP, Vartivarian S, Anaissie EJ, Samonis G, Bodet GP, Rinaldi M. Infections due to Cunninghamella bertholletiae in patients with cancer: reports of three cases and review. Clin Infect Dis. 1994;18:925–8.
- Pimentel JD, Dreyer G, Lum GD. Peritonitis due to Cunninghamella bertholletiae in a patient undergoing continuous ambulatory peritoneal dialysis. J Med Microbiol. 2006;55:115–8. CrossRef
- Sivakumar S, Mathews MS, George B. Cunninghamella pneumonia in postbone marrow transplant patient: first case report from India. Mycoses. 2005;48(5):360–2. CrossRef
- Ortín X, Escoda L, Llorente A, et al. Cunninghamella bertholletiae infection (mucormycosis) in a patient with acute T-cell lymphoblastic leukemia. Leuk Lymphoma. 2004;45(3):617–20.
- Quinio D, Karam A, Leroy JP, et al. Zygomycosis caused by Cunninghamella bertholletiae in a kidney transplant recipient. Med Mycol. 2004;42(2):177–80. CrossRef
- Zhang R, Zhang JW, Szerlip HM. Endocarditis and hemorrhagic stroke caused by Cunninghamella bertholletiae infection after kidney transplantation. Am J Kidney Dis. 2002;40(4):842–6. CrossRef
- Singh J, Rimek D, Kappe R. In vitro susceptibility of 15 strains of zygomycetes to nine antifungal agents as determined by the NCCLS M38-A microdilution method. Mycoses. 2005;48(4):246–50. CrossRef
- Guinea J, Pelaez T, Alcala L, Bouza E. Comparison of sensititre yeastone with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus. Diagn Microbiol Infect Dis. 2006;56(1):53–5. CrossRef
- McNulty JS. Rhinocerebral mucormycosis: predisposing factors. Laryngoscope. 1982;92:1140–3. CrossRef
- Honda A Kamei K, Unno H, Hiroshima K, Kuriyama T, Miyaji M. A murine model of zygomycosis by Cunninghamella bertholletiae. Mycopathologia. 1998–1999;144(3):141–6.
- Almyroudis NG, Sutton DA, Fothergill AW, Rinaldi MG, Kusne S. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrob Agents Chemother. 2007;51 (7):2587–90. CrossRef
- Vazquez L, Mateos JJ, Sanz-Rodriguez C, Perez E, Caballero D, San Miguel JF. Successful treatment of rhinocerebral zygomycosis with a combination of caspofungin and liposomal amphotericin B. Haematologica. 2005;90(12):ECR39.
- Mazade MA, Margolin JF, Rossmann SN, Edwards MS. Survival from pulmonary infection with Cunninghamella bertholletiae: case report and review of the literature. Pediatr Infect Dis J. 1998;17(9):835–9.
- Ng TT, Campbell CK, Rothera M, Houghton JB, Hughes D, Denning DW. Successful treatment of sinusitis caused by Cunninghamella bertholletiae. Clin Infect Dis. 1994;19:313–6.
- A Case of Cunninghamella bertholettiae Rhino-cerebral Infection in a Leukaemic Patient and Review of Recent Published Studies
Volume 165, Issue 6 , pp 407-410
- Cover Date
- Print ISSN
- Online ISSN
- Springer Netherlands
- Additional Links
- L-amphotericin B
- Cunninghamella bertholettiae
- Industry Sectors
- Author Affiliations
- 1. Division of Infectious Diseases, S. Martino Hospital, University of Genoa School of Medicine, 16132, Genoa, Italy
- 2. Section of Microbiology, S. Martino Hospital, University of Genoa School of Medicine, Genoa, Italy
- 3. Division of Haematology, S. Martino Hospital, University of Genoa School of Medicine, Genoa, Italy